Loading company…
NanoGhost is a pre-clinical drug-delivery technology company in Tel Aviv that uses modified adult stem cells to target cancer cells.
Established in 2019 and based in Tel Aviv, Israel, NanoGhost develops drug-delivery technology at the pre-clinical stage. Its approach loads medicine into modified adult stem cells that target cancer cells. In December 2019, the company raised USD 5 million in venture funding led by new investor aMoon.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in